Results for tag: "Relistor"

Relistor is a brand of medication used to treat opioid-induced constipation (OIC) in adults with chronic non-cancer pain. It is a peripherally-acting mu-opioid receptor antagonist (PAMORA) that works by blocking the effects of opioids on the gastrointestinal tract. This helps to reduce constipation and improve bowel movements. Relistor is administered as a subcutaneous injection and is available in both tablet and injection form. Relistor is part of a larger class of gastrointestinal drugs known as prokinetics. Prokinetics are medications that help to stimulate the muscles of the gastrointestinal tract, helping to improve the movement of food through the digestive system. Other drugs in this class include metoclopramide, domperidone, and cisapride. The Relistor market is a growing one, with more and more people being prescribed the medication for OIC. It is an important part of the overall gastrointestinal drug market, as it helps to improve the quality of life for those suffering from OIC. Some companies in the Relistor market include Salix Pharmaceuticals, AstraZeneca, and Progenics Pharmaceuticals. Show Less Read more